Paper30176897
A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
Saravu K and 12 others. Malar J, 2018. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India. Papers, record 30176897. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30176897
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Malaria, Vivax | Major topic |
| Plasmodium vivax | Major topic |
| Primaquine | Major topic |
| Adult | |
| Aged | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| India | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Recurrence | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MAC ID/SGA/2016/04 | Seed Grant Award by Manipal McGill Center for Infectious Diseases, MAHE, Manipal | PubMed |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27315280 | Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India. | PLoS One | 2016 | https://conductscience.org/library/papers/27315280 | PubMed |
| 2 | 29921273 | Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison. | Malar J | 2018 | https://conductscience.org/library/papers/29921273 | PubMed |
| 3 | 29190291 | malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication. | PLoS Med | 2017 | https://conductscience.org/library/papers/29190291 | PubMed |
| 4 | 22808048 | Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata. | PLoS One | 2012 | https://conductscience.org/library/papers/22808048 | PubMed |
| 5 | 27708188 | Epidemiology of Plasmodium vivax Malaria in India. | Am J Trop Med Hyg | 2016 | https://conductscience.org/library/papers/27708188 | PubMed |
| 6 | 27077309 | Primaquine treatment and relapse in Plasmodium vivax malaria. | Pathog Glob Health | 2016 | https://conductscience.org/library/papers/27077309 | PubMed |
| 7 | 9125831 | Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat. | Indian J Malariol | 1996 | https://conductscience.org/library/papers/9125831 | PubMed |
| 8 | 11425182 | The neglected burden of Plasmodium vivax malaria. | Am J Trop Med Hyg | 2001 | https://conductscience.org/library/papers/11425182 | PubMed |
| 9 | 28095658 | Therapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India. | Korean J Parasitol | 2016 | https://conductscience.org/library/papers/28095658 | PubMed |
| 10 | 9684649 | Studies on the Plasmodium vivax relapse pattern in Delhi, India. | Am J Trop Med Hyg | 1998 | https://conductscience.org/library/papers/9684649 | PubMed |
| 11 | 29889239 | Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria. | Clin Infect Dis | 2018 | https://conductscience.org/library/papers/29889239 | PubMed |
| 12 | 21989376 | Determinants of relapse periodicity in Plasmodium vivax malaria. | Malar J | 2011 | https://conductscience.org/library/papers/21989376 | PubMed |
| 13 | 28966050 | Malaria Epidemiology at the Clone Level. | Trends Parasitol | 2017 | https://conductscience.org/library/papers/28966050 | PubMed |
| 14 | 28367735 | Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India. | Pathog Glob Health | 2017 | https://conductscience.org/library/papers/28367735 | PubMed |
| 15 | 24752682 | Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru. | Am J Trop Med Hyg | 2014 | https://conductscience.org/library/papers/24752682 | PubMed |
| 16 | 24901334 | A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/24901334 | PubMed |
| 17 | 6721990 | Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6721990 | PubMed |
| 18 | 28750669 | Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia. | Malar J | 2017 | https://conductscience.org/library/papers/28750669 | PubMed |
| 19 | 29672516 | Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/29672516 | PubMed |
| 20 | 25107355 | Severity in Plasmodium vivax malaria claiming global vigilance and exploration--a tertiary care centre-based cohort study. | Malar J | 2014 | https://conductscience.org/library/papers/25107355 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42375875 | Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis. | Lancet Reg Health West Pac | 2026 | https://conductscience.org/library/papers/42375875 | PubMed |
| 42343401 | Adherence to 14-day primaquine treatment for radical cure of Plasmodium vivax and mixed malaria patients treated at health centers in Yilmana Densa district, Ethiopia: a community-based cross-sectional study. | Malar J | 2026 | https://conductscience.org/library/papers/42343401 | PubMed |
| 41239453 | Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. | Malar J | 2025 | https://conductscience.org/library/papers/41239453 | PubMed |
| 40506722 | Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting report. | Malar J | 2025 | https://conductscience.org/library/papers/40506722 | PubMed |
| 40112852 | 14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study. | Lancet Infect Dis | 2025 | https://conductscience.org/library/papers/40112852 | PubMed |
| 38123228 | Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis. | BMJ Glob Health | 2023 | https://conductscience.org/library/papers/38123228 | PubMed |
| 37817240 | Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. | Malar J | 2023 | https://conductscience.org/library/papers/37817240 | PubMed |
| 37748496 | Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. | Lancet Infect Dis | 2024 | https://conductscience.org/library/papers/37748496 | PubMed |
| 37383547 | Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India. | Lancet Reg Health Southeast Asia | 2023 | https://conductscience.org/library/papers/37383547 | PubMed |
| 35571076 | Methods to Assess Adult and Adolescent Patients' Adherence to Antimalarial Treatment: A Systematic Review. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35571076 | PubMed |
| 33891589 | Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure. | PLoS Med | 2021 | https://conductscience.org/library/papers/33891589 | PubMed |
| 32407682 | Plasmodium vivax in the Era of the Shrinking P. falciparum Map. | Trends Parasitol | 2020 | https://conductscience.org/library/papers/32407682 | PubMed |
| 31274189 | Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31274189 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| G6PD | 2539 | PubTator's text mining | https://conductscience.org/library/genes/2539 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| CTRI | CTRI/2017/03/007999 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30176897
GET https://conductscience.org/api/papers/v1/30176897/references?page=2